Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 8 studies | 27% ± 15% |
Insufficient scRNA-seq data for expression of GALR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 138.83 | 2420 / 2642 | 64% | 3.15 | 450 / 705 |
adrenal gland | 36% | 94.36 | 94 / 258 | 59% | 7.40 | 136 / 230 |
prostate | 85% | 124.36 | 208 / 245 | 3% | 0.05 | 13 / 502 |
intestine | 86% | 68.17 | 827 / 966 | 0% | 0 | 0 / 527 |
stomach | 73% | 48.66 | 262 / 359 | 0% | 0.00 | 1 / 286 |
adipose | 70% | 57.63 | 848 / 1204 | 0% | 0 | 0 / 0 |
breast | 63% | 42.23 | 287 / 459 | 0% | 0.00 | 2 / 1118 |
thymus | 58% | 34.15 | 381 / 653 | 1% | 0.01 | 4 / 605 |
esophagus | 58% | 44.97 | 840 / 1445 | 0% | 0 | 0 / 183 |
kidney | 31% | 12.10 | 28 / 89 | 9% | 0.50 | 82 / 901 |
skin | 38% | 13.95 | 680 / 1809 | 1% | 0.09 | 3 / 472 |
pancreas | 28% | 9.09 | 92 / 328 | 2% | 0.03 | 3 / 178 |
heart | 29% | 11.50 | 251 / 861 | 0% | 0 | 0 / 0 |
bladder | 29% | 6.19 | 6 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 15% | 5.36 | 202 / 1335 | 0% | 0 | 0 / 0 |
uterus | 10% | 4.71 | 17 / 170 | 1% | 0.08 | 4 / 459 |
ovary | 11% | 4.99 | 19 / 180 | 0% | 0 | 0 / 430 |
muscle | 3% | 0.82 | 23 / 803 | 0% | 0 | 0 / 0 |
lung | 2% | 0.80 | 12 / 578 | 1% | 0.02 | 9 / 1155 |
liver | 0% | 0.10 | 1 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007194 | Biological process | negative regulation of adenylate cyclase activity |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0051464 | Biological process | positive regulation of cortisol secretion |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0004966 | Molecular function | galanin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GALR1 |
Protein name | Galanin receptor type 1 (GAL1-R) (GALR-1) |
Synonyms | GALNR1 GALNR |
Description | FUNCTION: Receptor for the hormone galanin. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity. . |
Accessions | P47211 ENST00000299727.5 |